Antiviral peptides having a 2-oxoalkyl amino acid side chain
CA 1340682 C · Owner: Beaulieu, Pierre Louis · Inventors: Deziel, Robert; Beaulieu, Pierre Louis; Lavallee, Pierre
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed herein are peptide derivatives of the formula X-NR1-CH(R2)-C(W1)n-NH-CR3(R4)-C(W2)-NR5-CHCH2- C(O)-Y-C(W3)-NH-CR6-CR7(R8)-COOH-C(W4)-NH-CR9(R10)-Z wherein X is a terminal group, for example alkanoyl or phenyl-alkanoyl, radicals, R1 is hydrogen alkyl or phenylalkyl, R2, R4 and, R10 are selected from amino acid or derived amino acid residues R3, R5, R6, R7, R8 and R9 are hydrogen or lower alkyl W1, W2, W3, and W4 are oxo or thioxo, Y is for example, an alkyl or a cyclo-alkyl Z is a terminal group, for example, COOH or CH2OH and, n is 0 or 1. The derivatives are useful for treating herpes infections.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted July 27, 1999. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended July 27, 2016.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.